Biotechnology industries
Peninsula Pharmaceuticals Inc. and Placer Sierra Bancshares have both set the stage for their initial public offerings (IPOs) with filings to the U.S. Securities and Exchange Commission. Meanwhile, Liberman Broadcasting has revealed plans to raise a substantial sum in its IPO. Peninsula Pharmaceuticals Inc., a biopharmaceutical company, plans to
Biotechnology industries
The 4th Annual Life Science Ventures Conference, designed to showcase nearly 40 of the most exciting start-ups and early stage life science companies, is set to take place on March 9-10, 2004, at The Palace Hotel in San Francisco, California. The presenting companies have been carefully selected for their unique
Biotechnology industries
CoolSystems Inc.'s cutting-edge cooling technology has demonstrated impressive results in a University of Illinois at Peoria study, which found that using a liquid-cooled, soft-fabric "helmet" effectively dropped the brain temperature of stroke victims while minimizing the cooling of the body. The study, presented at the American
Biotechnology industries
This week's Initial Public Offering (IPO) lineup has drawn attention, with nearly a dozen companies set to make their trading debuts. Amidst the flurry of activity, Assurant Inc., a unit of Netherlands-based Fortis Insurance NV, is poised to make a significant splash. The company's $2 billion
Biotechnology industries
Analysts have expressed skepticism over the likelihood of Novartis AG attempting to rescue Aventis SA from the hostile bid made by Sanofi-Synthelabo SA. Sanofi's €48.5 billion offer has sparked rumors of potential white-knight bids, but Novartis appears to be focused on a merger with Roche Holding AG.
Health care industry
Model N, Inc., a leader in revenue execution software, has secured an $11 million investment to accelerate its expansion in the Life Science market. The funding was led by Meritech Capital Partners, a late stage venture capital fund, and included current investors Accel Partners and Accel KKR. Model N plans
Pharmaceutical industry
IPO filings reveal Eyetech Pharmaceuticals is preparing to list on the market this week, with a quartet of initial public offerings, including Tel Aviv-based electronics payments systems provider Lipman Electronic Engineering, beverage cup company Radnor Holdings Corp., and real estate investment trust Government Properties Trust Inc. The most highly anticipated
Pharmaceutical industry
Seventeen California life sciences companies participated in the California Biotechnology Trade Mission to BioEurope as delegates, projecting $590 to $760 million in new European market business over the coming three years. This mission was the third of three successful trade missions organized by Alameda-based ACET (Advancing California's Emerging
Health care industry
Ingenuity Systems has announced that Wyeth has purchased Ingenuity Pathways Analysis for use across the entire drug discovery and development chain from early discovery to clinical phases. This partnership marks a significant milestone in the application of Ingenuity's systems biology solutions in the pharmaceutical industry. The Ingenuity Pathways
Biotechnology industries
Immusol, a San Diego-based biopharmaceutical company, has announced the appointment of Nicholas F. Paoni, Ph.D. as its new Vice President of Therapeutics. Dr. Paoni will lead the development of the company's protein therapeutic and small molecule-based drug programs. With a background in chemistry and biochemistry, Dr. Paoni
Biotechnology industries
Therion Biologics Corporation has announced the licensing of patent rights related to lymphocyte function associated antigen-3 (LFA-3) from Biogen Idec Inc. This licenses adds to Therion's intellectual property portfolio, strengthening its proprietary position in advancing its lead cancer vaccine candidates, Prostvac-VF and Panvac-VF. The agreement allows Therion to
Biotechnology industries
The pace of consolidation in Germany's biotechnology sector continued Tuesday as two Munich-based biotech startups, Nadag AG and Sireen AG, agreed to merge and form Sirenade Pharmaceuticals AG. The move comes on the heels of other high-profile mergers in the sector, including the linking of DeveloGen AG and
